Overview
- Government figures published on Monday show roughly 4,900–5,000 confirmed cases and about 2,325 reported deaths, making this the deadliest Ebola epidemic recorded in the Democratic Republic of Congo.
- Laboratory testing has identified the outbreak as the Bundibugyo species, for which no licensed vaccine or targeted therapy exists, leaving care focused on isolation and supportive treatment.
- Health agencies warn transmission is unusually fast and undercounted because 60–70% of confirmed infections were not previously known contacts and many fatalities occur in homes rather than treatment centres.
- Ongoing armed conflict, weak health infrastructure and community mistrust are blocking contact tracing, safe burials and access to patients, which responders say lets the virus spread faster than teams can contain it.
- International aid and research are scaling up with new funding from Germany, the EU and the UN, mobile labs and tests deployed, clinical trials of antivirals under way and early lab work suggesting a Zaire-species vaccine might offer partial protection pending confirmation.